RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM)

被引：0
|
作者：
Berghoff, A. S. [1 ]
Bartsch, R. [1 ]
Bergen, E. [1 ]
Rudas, M. [2 ]
Gnant, M. [3 ]
Dieckmann, K. [4 ]
Pinker, K. [5 ]
Zielinski, C. C. [1 ]
Steger, G. G. [1 ]
Preusser, M. [1 ]
机构：
[1] Med Univ Vienna, Dept Med 1, Clin Div Oncol, Vienna, Austria
[2] Med Univ Vienna, Dept Pathol, Vienna, Austria
[3] Med Univ Vienna, Dept Surg, Vienna, Austria
[4] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria
[5] Med Univ Vienna, Dept Radiol, Vienna, Austria
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P08.01
引用
收藏
页数：1
相关论文
共 50 条
  • [1] T-DM1 in HER2-positive breast cancer brain metastases (BM).
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Rudas, Margareta
    Bergen, Elisabeth
    Gnant, Michael
    Dieckmann, Karin
    Pinker, Katja
    Zielinski, Christoph
    Steger, Guenther G.
    Preusser, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Activity of T-DM1 in HER2-positive breast cancer brain metastases
    Bartsch, Rupert
    Berghoff, Anna S.
    Vogl, Ursula
    Rudas, Margaretha
    Bergen, Elisabeth
    Gnant, Michael
    Dieckmann, Karin
    Pinker, Katja
    Bago-Horvath, Zsuzsanna
    Galid, Arik
    Oehler, Leopold
    Zielinksi, Christoph C.
    Steger, Guenther G.
    Preusser, Matthias
    CANCER RESEARCH, 2015, 75
  • [3] Activity of T-DM1 in HER2-positive breast cancer brain metastases
    Bartsch, R.
    Berghoff, A. S.
    Rudas, M.
    Bergen, E.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Preusser, M.
    Steger, G. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S184 - S184
  • [4] Activity of T-DM1 in Her2-positive breast cancer brain metastases
    Rupert Bartsch
    Anna S. Berghoff
    Ursula Vogl
    Margaretha Rudas
    Elisabeth Bergen
    Peter Dubsky
    Karin Dieckmann
    Katja Pinker
    Zsuzsanna Bago-Horvath
    Arik Galid
    Leopold Oehler
    Christoph C. Zielinski
    Michael Gnant
    Guenther G. Steger
    Matthias Preusser
    Clinical & Experimental Metastasis, 2015, 32 : 729 - 737
  • [5] Activity of T-DM1 in Her2-positive breast cancer brain metastases
    Bartsch, Rupert
    Berghoff, Anna S.
    Vogl, Ursula
    Rudas, Margaretha
    Bergen, Elisabeth
    Dubsky, Peter
    Dieckmann, Karin
    Pinker, Katja
    Bago-Horvath, Zsuzsanna
    Galid, Arik
    Oehler, Leopold
    Zielinski, Christoph C.
    Gnant, Michael
    Steger, Guenther G.
    Preusser, Matthias
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (07) : 729 - 737
  • [6] T-DM1 is active in Her2-positive breast cancer brain metastases
    Bartsch, R.
    Berghoff, A.
    Rudas, M.
    Bergen, E.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Steger, G. G.
    Preusser, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 195 - 195
  • [7] Trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer and brain metastases
    Jacot, W.
    Pons, E.
    Guiu, S.
    Levy, C.
    Frenel, J-S
    Bachelot, T.
    D'Hondt, V.
    Firmin, N.
    Romieu, G.
    Thezenas, S.
    Dalenc, F.
    CANCER RESEARCH, 2016, 76
  • [8] T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer
    Fabi, Alessandra
    Alesini, Daniele
    Valle, Enrichetta
    Moscetti, Luca
    Caputo, Roberta
    Caruso, Michele
    Carbognin, Luisa
    Ciccarese, Mariangela
    La Verde, Nicla
    Arpino, Grazia
    Cannita, Katia
    Paris, Ida
    Santini, Daniele
    Montemurro, Filippo
    Russillo, Michelangelo
    Ferretti, Gianluigi
    Filippelli, Gianfranco
    Rossello, Rosalba
    Fabbri, Agnese
    Zambelli, Alberto
    Leonardi, Vita
    D'Ottavi, Anna Maria
    Nistico, Cecilia
    Stani, Simonetta
    Giampaglia, Marianna
    Scandurra, Giusy
    Catania, Giovanna
    Malaguti, Paola
    Giannarelli, Diana
    Cognetti, Francesco
    BREAST, 2018, 41 : 137 - 143
  • [9] The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases
    Dong, Rongrong
    Ji, Jiali
    Liu, Hong
    He, Xuexin
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 143 : 20 - 26
  • [10] T-DM1 for HER2-positive metastatic breast cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (03): : E94 - E94
12345